Document:

Exhibit 10.1

 

Confidential

 

FORM OF SUBSCRIPTION AGREEMENT

 

Magnum Opus Acquisition Limited

Unit 1009, ICBC Tower

Three Garden Road

Central, Hong Kong

 

Ladies and Gentlemen:

 

This
Subscription Agreement (this “Subscription Agreement”) is being entered into as of the date set forth on the
signature page hereto, by and between Magnum Opus Acquisition Limited, an
exempted company incorporated in the Cayman Islands with limited liability (“SPAC”), and the undersigned
subscriber (the “Investor”), in connection with the Business Combination Agreement, dated as of August
26, 2021 (as may be amended, supplemented or otherwise modified from time to time, the “Business Combination
Agreement”), by and among SPAC, Integrated Whale Media Investment, Inc., a BVI business company incorporated in
the British Virgin Islands, in its capacity as a seller and in its capacity as the shareholders’ representative
(“IWM” or “Shareholders’ Representative”), Highlander Management LLC, a limited
liability company incorporated in the State of Delaware (“Highlander”),
Forbes Global Holdings Inc., a BVI business company incorporated in the British Virgin Islands (“FGH”) and Forbes
Global Media Holdings, Inc., a BVI business company incorporated in the British Virgin Islands
(“FGMH”), pursuant to which, among other things, IWM and Highlander shall transfer to SPAC, and SPAC
shall acquire, 100% of the issued share capital of FGH directly owned by IWM and 100% of the issued share capital of FGMH directly
owned by Highlander, on the terms and subject to the conditions therein (the transactions contemplated by the Business Combination
Agreement, including the share sale, the “Transaction”). In connection with the Transaction, SPAC is seeking
commitments from interested investors to purchase, contingent upon, and substantially concurrently with the closing of the
Transaction, Class A ordinary shares of SPAC, par value $0.0001 per share (the
“Shares”), in a private placement for a purchase price of $10.00 per share (the “Per Share Purchase
Price”). On or about or following the date of this Subscription Agreement, SPAC is entering into subscription agreements
with certain other investors (the “Other Investors” and together with the Investor, the
“Investors”), pursuant to which the Other Investors and the Investor have agreed or will agree to purchase on the
closing date of the Transaction Shares at the Per Share Purchase Price (the “Other Subscription Agreements” and
together with the Subscription Agreement, the “Subscription Agreements”). The aggregate purchase price to
be paid by the Investor for the subscribed Shares (as set forth on the signature page hereto) is referred to herein as the
“Subscription Amount.”

 

In connection therewith,
and in consideration of the foregoing and the mutual representations, warranties and covenants, and subject to the conditions, set forth
herein, and intending to be legally bound hereby, each of the Investor and SPAC acknowledges and agrees as follows:

 

1.            Subscription.
The Investor hereby irrevocably subscribes for and agrees to purchase from SPAC the number of Shares set forth on the signature page of
this Subscription Agreement on the terms and subject to the conditions provided for herein. The Investor acknowledges and agrees that
SPAC (with the written approval of IWM) reserves the right to accept or reject the Investor’s subscription for the Shares for any
reason or for no reason, in whole or in part, at any time prior to its acceptance, and the same shall be deemed to be accepted by SPAC
only when this Subscription Agreement is signed by a duly authorized person by or on behalf of SPAC; SPAC may do so in counterpart form.

 

2.            Closing.
The closing of the sale of the Shares contemplated hereby (the “Closing”) is contingent upon the substantially concurrent
consummation of the Transaction. The Closing shall occur on the date of, and substantially concurrently with and conditioned upon the
effectiveness of, the Transaction. Upon (a) satisfaction or waiver of the conditions set forth in Section 3 below and (b) delivery
of written notice from (or on behalf of) SPAC to the Investor (the “Closing Notice”), that SPAC reasonably expects
all conditions to the closing of the Transaction to be satisfied or waived on a date that is not less than five (5) business days
from the date on which the Closing Notice is delivered to the Investor, the Investor shall deliver to SPAC, three (3) business days
prior to the closing date specified in the Closing Notice (the “Closing Date”), (i) the Subscription Amount by
wire transfer of United States dollars in immediately available funds to the account(s) specified by SPAC in the Closing Notice
and (ii) any other information that is reasonably requested in the Closing Notice in order for SPAC to issue the Investor’s
Shares, including, without limitation, the legal name of the person in whose name such Shares are to be issued and a duly executed Internal
Revenue Service Form W-9 or W-8, as applicable. On the Closing Date, SPAC shall issue a number of Shares to the Investor set forth
on the signature page to this Subscription Agreement and subsequently cause such Shares to be registered in book entry form in the
name of the Investor on SPAC’s share register; provided, however, that SPAC’s obligation to issue the Shares
to the Investor is contingent upon SPAC having received the Subscription Amount in full accordance with this Section 2. If
the Closing does not occur within ten (10) business days following the Closing Date specified in the Closing Notice, SPAC shall
promptly (but not later than one (1) business day thereafter) return the Subscription Amount in full to the Investor. For purposes
of this Subscription Agreement, “business day” shall mean a day other than a Saturday, Sunday or other day on which commercial
banks in New York, New York, Hong Kong, the Cayman Islands or the British Virgin Islands are authorized or required by law to close.

 

     

     

    

 

Confidential

 

3.            Closing
Conditions.

 

a.            The
obligation of the parties hereto to consummate the purchase and sale of the Shares pursuant to this Subscription Agreement is subject
to the following conditions:

 

(i)            no
applicable governmental authority shall have enacted, issued, promulgated, enforced or entered any judgment, order, law, rule or
regulation (whether temporary, preliminary or permanent) which is then in effect and has the effect of making the consummation of the
transactions contemplated hereby illegal or otherwise restraining or prohibiting consummation of the transactions contemplated hereby;
and

 

(ii)            all
conditions precedent to the closing of the Transaction under the Business Combination Agreement shall have been satisfied (as determined
by the parties to the Business Combination Agreement and other than those conditions under the Business Combination Agreement which,
by their nature, are to be fulfilled at the closing of the Transaction, including to the extent that any such condition is dependent
upon the consummation of the purchase and sale of the Shares pursuant to this Subscription Agreement) or waived, and the closing of the
Transaction shall be scheduled to occur promptly following the Closing.

 

b.            The
obligation of SPAC to consummate the issuance and sale of the Shares pursuant to this Subscription Agreement shall be subject to the
conditions that (i) all representations and warranties of the Investor contained in this Subscription Agreement are true and correct
in all material respects (other than representations and warranties that are qualified as to materiality, which representations and warranties
shall be true in all respects) at and as of the Closing Date, and consummation of the Closing shall constitute a reaffirmation by the
Investor of each of the representations and warranties of the Investor contained in this Subscription Agreement as of the Closing Date
and (ii) all obligations, covenants and agreements of the Investor required to be performed by it at or prior to the Closing Date
shall have been performed in all material respects.

 

    2

     

    

 

Confidential

 

c.            The
obligation of the Investor to consummate the purchase of the Shares pursuant to this Subscription Agreement shall be subject to the conditions
that (i) all representations and warranties of SPAC contained in this Subscription Agreement shall be true and correct in all material
respects (other than representations and warranties that are qualified as to materiality or Material Adverse Effect (as defined herein),
which representations and warranties shall be true in all respects) at and as of the Closing Date, and consummation of the Closing shall
constitute a reaffirmation by SPAC of each of the representations and warranties of SPAC contained in this Subscription Agreement as
of the Closing Date and (ii) all obligations, covenants and agreements of SPAC required by the Subscription Agreement to be performed
by it at or prior to the Closing Date shall have been performed in all material respects.

 

4.            Further
Assurances. At or prior to the Closing Date, the parties hereto shall execute and deliver or cause to be executed and delivered such
additional documents and take such additional actions as the parties reasonably may deem to be practical and necessary in order to consummate
the subscription as contemplated by this Subscription Agreement.

  

5.            SPAC
Representations and Warranties. SPAC represents and warrants to the Investor that:

 

a.            SPAC
is an exempted company with limited liability duly incorporated, validly existing and in good standing under the laws of the Cayman Islands,
and has all requisite corporate power and authority and all authorizations, licenses and permits necessary to own, lease and operate
its properties and to carry on its businesses as now conducted and to enter into, deliver and perform its obligations under this Subscription
Agreement.

 

b.            As
of the Closing Date, the Shares will be duly authorized and, when issued and delivered to the Investor against full payment therefor
in accordance with the terms of this Subscription Agreement, the Shares will be validly issued, fully paid and non-assessable and will
not have been issued in violation of or subject to any preemptive or similar rights created under the Amended and Restated Memorandum
and Articles of Association of SPAC (as adopted prior to the Closing Date) or under the laws of the Cayman Islands.

 

c.            This
Subscription Agreement has been duly authorized, executed and delivered by SPAC and, assuming that this Subscription Agreement constitutes
the valid and binding agreement of the Investor, this Subscription Agreement constitutes a valid and binding obligation of SPAC, enforceable
in accordance with its terms, except as enforceability may be limited by bankruptcy laws, other similar laws affecting creditors’
rights and general principles of equity affecting the availability of specific performance and other equitable remedies.

 

d.            The
issuance and sale of the Shares and the compliance by SPAC with all of the provisions of this Subscription Agreement and the consummation
of the transactions contemplated herein will be done in accordance with the rules of The New York Stock Exchange (the “NYSE”)
and will not (i) conflict with or result in a breach or violation of any of the terms or provisions of, or constitute a default
under, or result in the creation or imposition of any lien, charge or encumbrance upon any of the property or assets of SPAC or any of
its subsidiaries pursuant to the terms of any indenture, mortgage, deed of trust, loan agreement, lease, license or other agreement or
instrument to which SPAC or any of its subsidiaries is a party or by which SPAC or any of its subsidiaries is bound or to which any of
the property or assets of SPAC is subject that would reasonably be expected to have a material adverse effect on the business, financial
condition or results of operations of SPAC and its subsidiaries, taken as a whole (a “Material
Adverse Effect”) or materially affect the validity of the Shares or the legal authority of SPAC to timely comply in all material
respects with the terms of this Subscription Agreement; (ii) result in any violation of the provisions of the organizational documents
of SPAC; or (iii) result in any violation of any statute or any judgment, order, rule or regulation of any court or governmental
agency or body, domestic or foreign, having jurisdiction over SPAC or any of its properties that would reasonably be expected to have
a Material Adverse Effect or materially affect the validity of the Shares or the legal authority of SPAC to timely comply in all material
respects with its obligations under this Subscription Agreement.

 

    3

     

    

 

Confidential

  

e.            As
of their respective dates, all reports (the “SEC Reports”) required to be filed by SPAC with the U.S. Securities and
Exchange Commission (the “SEC”) complied in all material respects with the applicable requirements of the Securities
Act of 1933, as amended (the “Securities Act”) and the Securities Exchange Act of 1934, as amended (the “Exchange
Act”), and the rules and regulations of the SEC promulgated thereunder, and none of the SEC Reports, when filed, contained
any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make
the statements therein, in the light of the circumstances under which they were made, not misleading.

  

f.            SPAC
has not entered into any agreement or arrangement entitling any agent, broker, investment banker, financial advisor or other person to
any broker’s or finder’s fee or any other commission or similar fee in connection with the transactions contemplated by this
Subscription Agreement for which the Investor could become liable. Other than JonesTrading Institutional Services LLP (the “Placement
Agent”), SPAC is not aware of any person that has been or will be paid, directly or indirectly, remuneration for solicitation of
purchasers in connection with the sale of any Shares in this offering.

 

g.            Assuming
the accuracy of the Investor’s representations and warranties set forth in Section 6, no registration under the Securities
Act is required for the offer and sale of the Shares by SPAC to the Investor hereunder. The Shares (i) were not offered by any form
of general solicitation or general advertising and (ii) are not being offered in a manner involving a public offering under, or
in a distribution in violation of, the Securities Act, or any state securities laws.

  

h.            As
of the date of entry into the Business Combination Agreement, the authorized share capital of SPAC consists of (i) 500,000,000 Class A
ordinary shares, (ii) 50,000,000 Class B ordinary shares and (iii) 5,000,000 preferred shares, each with a par value of
$0.0001 per share. As of the date of entry into the Business Combination Agreement, (A) 20,000,000 Class A ordinary shares
of SPAC are issued and outstanding, (B) 5,000,000 Class B ordinary shares of SPAC are issued and outstanding, (C) 16,000,000
warrants to purchase Class A ordinary shares of SPAC are issued and outstanding,
and (D) no preferred shares are issued and outstanding. All (1) issued and outstanding Class A ordinary shares and Class B
ordinary shares of SPAC have been duly authorized and validly issued, are fully paid and are non-assessable and (2) outstanding
warrants have been duly authorized and validly issued. Except as set forth above and pursuant to the Other Subscription Agreements, the
Business Combination Agreement and the other agreements and arrangements referred to therein or in the SEC Reports, as of the date of
entry into the Business Combination Agreement, there are no outstanding options, warrants or other rights to subscribe for, purchase
or acquire from SPAC any Class A ordinary shares, Class B ordinary shares or other equity interests in SPAC, or securities
convertible into or exchangeable or exercisable for such equity interests. As of the date of entry into the Business Combination Agreement,
SPAC has no direct or indirect subsidiaries.

 

i.            As
of the date of entry into the Business Combination Agreement, the issued and outstanding Shares of SPAC are registered pursuant to Section 12(b) of
the Exchange Act, and are listed for trading on the NYSE under the symbol “OPA” (it being understood that the trading symbol
will be changed in connection with the Transaction). Except as disclosed in SPAC’s filings with the SEC, as of the date of entry
into the Business Combination Agreement, there is no suit, action, proceeding or investigation pending or, to the knowledge of SPAC,
threatened against SPAC by the NYSE or the SEC, respectively, to prohibit or terminate the listing of SPAC’s Shares on the NYSE,
or to deregister the Shares under the Exchange Act. SPAC has taken no action that is designed to terminate the registration of the Shares
under the Exchange Act.

 

    4

     

    

 

Confidential

 

6.            Investor
Representations and Warranties. The Investor represents and warrants to SPAC and the Placement Agent that:

 

a.            The
Investor, or each of the funds managed by or affiliated with the Investor for which the Investor is acting as nominee, as applicable,
(i) is a “qualified institutional buyer” (within the meaning of Rule 144A under the Securities Act), or an “accredited
investor” (within the meaning of Rule 501(a) of Regulation D under the Securities Act) as indicated in the questionnaire
attached hereto as Schedule A, and a sophisticated investor, experienced in investing in private equity transactions and capable
of evaluating investment risks independently, both in general and with regard to all transactions and investment strategies involving
a security or securities, including his, her or its participation in the Transaction, (ii) is acquiring the Shares only for his,
her or its own account and not for the account of others, or if the Investor is subscribing for the Shares as a fiduciary or agent for
one or more investor accounts, the Investor has full investment discretion with respect to each such account, and the full power and
authority to make the acknowledgements, representations and agreements herein on behalf of each owner of each such account, and (iii) is
not acquiring the Shares with a view to, or for offer or sale in connection with, any distribution thereof in violation of the Securities
Act (and shall provide the requested information set forth on Schedule A). The Investor is not an entity formed for the specific
purpose of acquiring the Shares and is an “institutional account” as defined by FINRA Rule 4512(c). The Investor has
determined based on its own independent review and such professional advice as it deems appropriate that its purchase of the Shares and
participation in the Transaction (i) are fully consistent with its financial needs, objectives and condition, (ii) comply and
are fully consistent with all investment policies, guidelines and other restrictions applicable to the Investor, (iii) have been
duly authorized and approved by all necessary action, (iv) do not and will not violate or constitute a default under its charter,
by-laws or other constituent document or under any law, rule, regulation, agreement or other obligation by which the Investor is bound
and (v) are a fit, proper and suitable investment for the Investor, notwithstanding the substantial risks inherent in investing
in or holding the Shares. The Investor is able to bear the substantial risks associated with its purchase of the Shares, including but
not limited to loss of its entire investment therein.

 

b.            The
Investor acknowledges and agrees that the Shares are being offered in a transaction not involving any public offering within the meaning
of the Securities Act and that the Shares have not been registered under the Securities Act. The Investor acknowledges and agrees that
the Shares may not be offered, resold, transferred, pledged, mortgaged or otherwise disposed of by the Investor absent an effective registration
statement under the Securities Act except (i) to SPAC or a subsidiary thereof, (ii) to non-U.S. persons pursuant to offers
and sales that occur outside the United States within the meaning of Regulation S under the Securities Act or (iii) pursuant to
another applicable exemption from the registration requirements of the Securities Act, and in each of clauses (i) and (iii) in
accordance with any applicable securities laws of the states and other jurisdictions of the United States, and that any certificates
representing the Shares shall contain a restrictive legend to such effect. The Investor acknowledges and agrees that the Shares will
be subject to transfer restrictions and, as a result of these transfer restrictions, the Investor may not be able to readily offer, resell,
transfer, pledge, mortgaged or otherwise dispose of the Shares and may be required to bear the financial risk of an investment in the
Shares for an indefinite period of time. The Investor acknowledges and agrees that, to the extent the investor decides to rely upon Rule 144
as an exemption from the registration requirements of the Securities Act, the Shares will not be eligible for offer, resale, transfer,
pledge, mortgage or disposition pursuant to Rule 144 promulgated under the Securities Act until at least one (1) year from
the Closing Date. The Investor acknowledges and agrees that it has been advised to consult legal counsel and tax and accounting advisors
prior to making any offer, resale, transfer, pledge, mortgage or disposition of any of the Shares.

 

c.            The
Investor acknowledges and agrees that the Investor is purchasing the Shares directly from SPAC. The Investor further acknowledges that
there have been no representations, warranties, covenants and agreements made to the Investor by or on behalf of SPAC, FGH, FGMH, IWM,
Highlander or any of their respective affiliates or any control persons, shareholders, officers, directors, employees, partners, agents
or representatives of any of the foregoing or any other person or entity, expressly or by implication, other than those representations,
warranties, covenants and agreements of SPAC expressly set forth in Section 5 of this Subscription Agreement. The Investor acknowledges
and agrees that certain information provided by or on behalf of SPAC, FGH, FGMH, IWM and Highlander was based on projections, and
such projections were prepared based on assumptions and estimates that are inherently uncertain and are subject to a wide variety of
significant business, economic and competitive risks, uncertainties and contingencies (including those included in the investor presentation
provided to the Investor)that could cause actual results to differ materially from those contained in the projections and that such projections
are not a guarantee of financial performance. The Investor further acknowledges and agrees that the information provided to the Investor
is subject to change.

 

    5

     

    

 

Confidential

 

d.            The
Investor’s acquisition and holding of the Shares will not constitute or result in a non-exempt prohibited transaction under Section 406
of the Employee Retirement Income Security Act of 1974, as amended, Section 4975 of the Internal Revenue Code of 1986, as amended,
or any applicable similar law.

 

e.            The
Investor acknowledges and agrees that in making an investment decision with respect to the Shares, SPAC, the Transaction, and the business
of FGH and FGMH and their subsidiaries, the Investor has relied exclusively on (i) the offering materials made available to the
Investor in connection with the Transaction, (ii) the Investor’s own sources of information, and his, her or its independent
investment analysis and due diligence and (iii) the representations and warranties of SPAC contained in Section 5 of this Subscription
Agreement. Without limiting the generality of the foregoing, the Investor acknowledges that he, she or it has reviewed SPAC’s filings
with the SEC. The Investor acknowledges and agrees that the Investor and the Investor’s professional advisor(s), if any, have had
the full opportunity to ask such questions, receive such answers and obtain such information as the Investor and such Investor’s
professional advisor(s), if any, have deemed necessary to make an investment decision with respect to the Shares. The Investor acknowledges
and agrees that SPAC continues to review the “Staff Statement on Accounting and Reporting Considerations for Warrants Issued by
Special Purpose Acquisition Companies” issued by the SEC staff on April 12, 2021 and its implications, including on the financial
statements and other information included in its filings with the SEC, and any restatement, revision or other modification of such filings
relating to or arising from such review, any subsequent related agreements or other guidance from the SEC staff shall be deemed not material
for purposes of this Subscription Agreement. The Investor agrees that the Placement Agent and each of its respective members, directors,
officers, employees, representatives and controlling persons have neither conducted any independent investigation nor prepared any disclosure
or offering document with respect to SPAC, FGH, FGMH or the Shares or the accuracy, completeness or adequacy of any information supplied
to the Investor by SPAC. In connection with the issue and purchase of the Shares, the Placement Agent has not acted as the Investor’s
financial advisor or fiduciary. The Investor acknowledges that the Placement Agent does not assume any responsibility for independent
verification of, or the accuracy or completeness of, any information or projections provided to the Investor hereunder.

 

f.            The
Investor became aware of this offering of the Shares solely by means of direct contact between the Investor and SPAC or the Placement
Agent or a representative of SPAC or the Placement Agent, and the Shares were offered to the Investor solely by direct contact between
the Investor and SPAC, the Placement Agent or a representative of SPAC or the Placement Agent. The Investor did not become aware of this
offering of the Shares, nor were the Shares offered to the Investor, by any other means. The Investor acknowledges that the Shares (i) were
not offered by any form of general solicitation or general advertising and (ii) are not being offered in a manner involving a public
offering under, or in a distribution in violation of, the Securities Act, or any state securities laws. The Investor
acknowledges that it is not relying upon, and has not relied upon, any statement, representation or warranty made by any person (including,
without limitation, SPAC, FGH, FGMH, IWM, Highlander or any of their respective affiliates or any control persons, officers, directors,
employees, partners, agents or representatives of any of the foregoing), other than the representations and warranties of SPAC contained
in Section 5 of this Subscription Agreement, in making its investment or decision to invest in SPAC.

 

    6

     

    

 

Confidential

 

g.            The
Investor acknowledges that it is aware that there are substantial risks incident to the purchase and ownership of the Shares, including
those set forth in SPAC’s filings with the SEC. The Investor has such knowledge and experience in financial and business matters
as to be capable of evaluating the merits and risks of an investment in the Shares, and the Investor has sought such accounting, legal
and tax advice as the Investor has considered necessary to make an informed investment decision and the Investor has made its own assessment
and has satisfied itself concerning relevant tax and other economic considerations relative to its purchase of the Shares. The Investor
acknowledges that Investor shall be responsible for any of the Investor’s tax liabilities that may arise as a result of the transactions
contemplated by this Subscription Agreement, and that none of SPAC, FGH, FGMH, IWM or Highlander have provided any tax advice or
any other representations or guarantee regarding the tax consequence of the transactions contemplated by this Subscription Agreement.

 

h.            Alone,
or together with any professional advisor(s), the Investor has adequately analyzed and fully considered the risks of an investment in
the Shares and determined that the Shares are a suitable investment for the Investor and that the Investor is able at this time and in
the foreseeable future to bear the economic risk of a total loss of the Investor’s investment in SPAC. The Investor acknowledges
specifically that a possibility of total loss exists.

  

i.            The
Investor acknowledges and agrees that no federal or state agency has passed upon or endorsed the merits of this offering of the Shares
or made any findings or determination as to the fairness of this investment.

 

j.            The
Investor, if not an individual, has been duly formed or incorporated and is validly existing and is in good standing under the laws of
its jurisdiction of formation or incorporation, with power and authority to enter into, deliver and perform its obligations under this
Subscription Agreement.

 

k.            The
execution, delivery and performance by the Investor of this Subscription Agreement are within the powers of the Investor, have been duly
authorized and will not constitute or result in a breach or default under or conflict with any order, ruling or regulation of any court
or other tribunal or of any governmental commission or agency, or any agreement or other undertaking, to which the Investor is a party
or by which the Investor is bound, and, if the Investor is not an individual, will not violate any provisions of the Investor’s
organizational documents, including, without limitation, its incorporation or formation papers, bylaws, indenture of trust or partnership
or operating agreement, as may be applicable. The signature on this Subscription Agreement is genuine, and the signatory, if the Investor
is an individual, has legal competence and capacity to execute the same or, if the Investor is not an individual, the signatory has been
duly authorized to execute the same, and, assuming that this Subscription Agreement constitutes the valid and binding obligation of SPAC,
this Subscription Agreement constitutes a legal, valid and binding obligation of the Investor, enforceable in accordance with its terms,
except as enforceability may be limited by bankruptcy laws, other similar laws affecting creditors’ rights and general principles
of equity affecting the availability of specific performance and other equitable remedies.

  

l.            The
Investor is not (i) a person named on the List of Specially Designated Nationals and Blocked Persons administered by the U.S. Treasury
Department’s Office of Foreign Assets Control (“OFAC”) or in any Executive Order issued by the President of
the United States and administered by OFAC (“OFAC List”), or a person or entity prohibited by any OFAC sanctions program,
(ii) owned, directly or indirectly, or controlled by, or acting on behalf of, one or more persons that are named on the OFAC List;
(iii) organized, incorporated, established, located, resident or born in, or a citizen, national or the government, including any
political subdivision, agency or instrumentality thereof, of, Cuba, Iran, North Korea, Syria, the Crimea region of Ukraine or any
other country or territory embargoed or subject to substantial trade restrictions by the United States, (iv) a Designated National
as defined in the Cuban Assets Control Regulations, 31 C.F.R. Part 515, or (v) a non-U.S. shell bank or providing banking services
directly or indirectly to a non-U.S. shell bank (each, a “Prohibited Investor”). The Investor agrees to provide law
enforcement agencies, if requested thereby, such records as required by applicable law, provided that the Investor is permitted to do
so under applicable law. If the Investor is a financial institution subject to the Bank Secrecy Act (31 U.S.C. Section 5311 et seq.),
as amended by the USA PATRIOT Act of 2001 (the “PATRIOT Act”), and its implementing regulations (collectively, the
 “BSA/PATRIOT Act”), the Investor maintains policies and procedures reasonably designed to comply with applicable obligations
under the BSA/PATRIOT Act. To the extent required, it maintains policies and procedures reasonably designed to ensure compliance with
OFAC-administered sanctions programs, including for the screening of its investors against the OFAC sanctions programs, including the
OFAC List. The Investor represents that to the extent required by applicable law, the Investor maintains policies and procedures reasonably
designed to ensure that the funds held by the Investor and used to purchase the Shares were legally derived and were not obtained, directly
or indirectly, from a Prohibited Investor.

 

    7

     

    

 

Confidential

 

m.            No
foreign person (as defined in 31 C.F.R. Part 800.224) in which the national or subnational governments of a single foreign state
have a substantial interest (as defined in 31 C.F.R. Part 800.244) will acquire a substantial interest in SPAC as a result of the
purchase and sale of the Shares hereunder such that a declaration to the Committee on Foreign Investment in the United States would be
mandatory under 31 C.F.R. Part 800.401, and no foreign person will have control (as defined in 31 C.F.R. Part 800.208) over
SPAC from and after the Closing as a result of the purchase and sale of the Shares hereunder.

  

n.            The
Investor agrees and undertakes to provide such information as is reasonably requested by the Placement Agent to satisfy the Placement
Agent’s obligations under any applicable “know your customer” and/or anti-money laundering rules and regulations,
including the BSA/PATRIOT Act and/or the “Customer Due Diligence Rule” (31 C.F.R. 1010.230).

 

o.            The
Investor has or has commitments to have and, when required to deliver payment to SPAC pursuant
to Section 2 above, will have, sufficient funds to pay the Subscription Amount and consummate the purchase and sale of the Shares
pursuant to this Subscription Agreement.

 

p.            The
Investor does not have, as of the date hereof, any “put equivalent position” as such term is defined in Rule 16a-1 under
the Exchange Act or short sale positions with respect to the securities of SPAC. Notwithstanding the foregoing, in the case of an Investor
that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such Investor’s assets
and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers managing other portions
of such Investor’s assets, the representation set forth above shall only apply with respect to the portion of assets managed by
the portfolio manager that made the investment decision to purchase the Shares covered by this Subscription Agreement.

 

7.            Registration
Rights.

 

a.            In
the event that the Shares are not registered in connection with the consummation of the Transaction, SPAC agrees that, within sixty (60)
days after the Closing Date, it will file with the SEC (at its sole cost and expense) a registration statement registering the resale
of the Shares (the “Registration Statement”), and it shall use its commercially reasonable efforts to have the Registration
Statement declared effective as soon as practicable after the filing thereof, but no later than the earlier of (i) one hundred-five
(105) days after the filing thereof (or one hundred-sixty five (165) days after
the filing thereof if the SEC notifies SPAC that it will “review” the Registration Statement) and (ii) ten (10) business
days after SPAC is notified by the SEC that the Registration Statement will not be “reviewed” or will not be subject to further
review. In connection with the foregoing, Investor shall not be required to execute any lock-up or similar agreement or otherwise
be subject to any contractual restriction on the ability to transfer the Shares. SPAC agrees to cause such Registration Statement, or
another shelf registration statement that includes the Shares to be sold pursuant to this Subscription Agreement, to remain effective
until the earliest of (i) the second anniversary of the Closing, (ii) the date on which the Investor ceases to hold any Shares
issued pursuant to this Subscription Agreement, or (iii) on the first date on which the Investor is able to sell all of its Shares
issued pursuant to this Subscription Agreement (or shares received in exchange therefor) under Rule 144 promulgated under the Securities
Act (“Rule 144”) without compliance with the volume or manner of sale limitations of such rule. Prior to the
effective date of the Registration Statement, SPAC will use commercially reasonable efforts to qualify the Shares for listing on the
applicable stock exchange. The Investor agrees to disclose its ownership to SPAC upon request to assist it in making the determination
with respect to Rule 144 described in clause (iii) above. SPAC may amend the Registration Statement so as to convert the Registration
Statement to a Registration Statement on Form S-3 at such time after SPAC becomes eligible to use such Form S-3. The Investor
acknowledges and agrees that SPAC may suspend the use of any such registration statement if it determines that in order for such registration
statement not to contain a material misstatement or omission, an amendment thereto would be needed to include information that would
at that time not otherwise be required in a current, quarterly, or annual report under the Exchange Act, provided, that, (I) SPAC
shall not so delay filing or so suspend the use of the Registration Statement for a period of more than seventy-five (75) consecutive
days or more than a total of one hundred-twenty (120) days in any twelve (12) month period and (II) SPAC shall use commercially
reasonable efforts to make such Registration Statement available for the sale by the Investor of such securities as soon as practicable
thereafter. SPAC’s obligations to include the Shares issued pursuant to this Subscription Agreement (or shares issued in exchange
therefor) for resale in the Registration Statement are contingent upon the Investor furnishing in writing to SPAC such information regarding
the Investor, the securities of SPAC held by the Investor and the intended method of disposition of such Shares, which shall be limited
to non-underwritten public offerings, as shall be reasonably requested by SPAC to effect the registration of such Shares, and execution
of such documents in connection with such registration as SPAC may reasonably request that are customary of a selling shareholder in
similar situations.

 

    8

     

    

 

Confidential

  

b.            Indemnification

  

(i)            SPAC
agrees to indemnify and hold harmless, to the extent permitted by law, the Investor, its directors, and officers, employees, and agents,
and each person who controls the Investor (within the meaning of the Securities Act or the Exchange Act) and each affiliate of the Investor
(within the meaning of Rule 405 under the Securities Act) from and against any and all out-of-pocket losses, claims, damages, liabilities
and expenses (including, without limitation, any reasonable and documented attorneys’ fees and expenses incurred in connection
with defending or investigating any such action or claim) caused by any untrue or alleged untrue statement of material fact contained
in any Registration Statement, prospectus included in any Registration Statement or preliminary prospectus or any amendment thereof or
supplement thereto or any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements
therein not misleading, except insofar as the same are caused by or contained in any information furnished in writing to SPAC
by or on behalf of the Investor expressly for use therein.

 

(ii)            The
Investor agrees, severally and not jointly with any person that is a party to the Other Subscription Agreements, to indemnify and hold
harmless SPAC, its directors and officers and agents and each person who controls SPAC (within the meaning of the Securities Act) against
any losses, claims, damages, liabilities and expenses (including, without limitation, reasonable and documented attorneys’ fees)
resulting from any untrue or alleged untrue statement of material fact contained in the Registration Statement, prospectus or preliminary
prospectus or any amendment thereof or supplement thereto or any omission or alleged omission of a material fact required to be stated
therein or necessary to make the statements therein not misleading, but only to the extent that such untrue statement or omission is
contained (or not contained in, in the case of an omission) in any information or affidavit so furnished in writing by or on behalf of
the Investor expressly for use therein. In no event shall the liability of the Investor be greater in amount than the dollar amount of
the net proceeds received by the Investor upon the sale of the Shares purchased pursuant to this Subscription Agreement giving rise to
such indemnification obligation.

 

    9

     

    

 

Confidential

  

(iii)            Any
person entitled to indemnification herein shall (1) give prompt written notice to the indemnifying party of any claim with respect
to which it seeks indemnification (provided that the failure to give prompt notice shall not impair any person’s right to indemnification
hereunder to the extent such failure has not prejudiced the indemnifying party) and (2) permit such indemnifying party to assume
the defense of such claim with counsel reasonably satisfactory to the indemnified party. If such defense is assumed, the indemnifying
party shall not be subject to any liability for any settlement made by the indemnified party without its consent, such consent not to
be unreasonably withheld. An indemnifying party who elects not to assume the defense of a claim shall not be obligated to pay the fees
and expenses of more than one counsel for all parties indemnified by such indemnifying party with respect to such claim, unless in the
reasonable judgment of legal counsel to any indemnified party a conflict of interest exists between such indemnified party and any other
of such indemnified parties with respect to such claim. No indemnifying party shall, without the consent of the indemnified party, consent
to the entry of any judgment or enter into any settlement which cannot be settled in all respects by the payment of money (and such money
is so paid by the indemnifying party pursuant to the terms of such settlement) or which settlement does not include as an unconditional
term thereof the giving by the claimant or plaintiff to such indemnified party of a release from all liability in respect to such claim
or litigation.

 

(iv)            The
indemnification provided for under this Subscription Agreement shall remain in full force and effect regardless of any investigation
made by or on behalf of the indemnified party or any officer, director, employee, agent, affiliate or controlling person of such indemnified
party and shall survive the transfer of the Shares purchased pursuant to this Subscription Agreement.

  

(v)            If
the indemnification provided under this Section 7(b) from the indemnifying party is unavailable or insufficient to hold harmless
an indemnified party in respect of any losses, claims, damages, liabilities and expenses referred to herein, then the indemnifying party,
in lieu of indemnifying the indemnified party, shall contribute to the amount paid or payable by the indemnified party as a result of
such losses, claims, damages, liabilities and expenses in such proportion as is appropriate to reflect the relative fault of the indemnifying
party and the indemnified party, as well as any other relevant equitable considerations. The relative fault of the indemnifying party
and indemnified party shall be determined by reference to, among other things, whether any action in question, including any untrue or
alleged untrue statement of a material fact or omission or alleged omission to state a material fact, was made by (or not made by, in
the case of an omission), or relates to information supplied by (or not supplied by, in the case of an omission) or on behalf of, such
indemnifying party or indemnified party, and the indemnifying party’s and indemnified party’s relative intent, knowledge,
access to information and opportunity to correct or prevent such action. The amount paid or payable by a party as a result of the losses
or other liabilities referred to above shall be deemed to include, subject to the limitations set forth above, any legal or other fees,
charges or expenses reasonably incurred by such party in connection with any investigation or proceeding. No person guilty of fraudulent
misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution pursuant to
this Section 7(b) from any person who was not guilty of such fraudulent misrepresentation. Any contribution pursuant to this
Section 7(b)(v) by any seller of Shares shall be limited in amount to the amount of net proceeds received by such seller from
the sale of such Shares pursuant to the Registration Statement. Notwithstanding anything to the contrary herein, in no event will any
party be liable for consequential, special, exemplary or punitive damages in connection with this Subscription Agreement.

 

    10

     

    

 

Confidential

 

8.            Termination.
This Subscription Agreement shall terminate and be void and of no further force and effect, and all rights and obligations of the parties
hereunder shall terminate without any further liability on the part of any party in respect thereof, upon the earlier to occur of (a) such
date and time as the Business Combination Agreement is terminated in accordance with its terms without being consummated, (b) upon
the mutual written agreement of each of the parties hereto and the Shareholders’ Representative, (c) 30 days after the Termination
Date (as defined in the Business Combination Agreement as in effect on the date hereof), if the Closing has not occurred by such date
other than as a result of a breach of Investor’s obligations hereunder, or (d) if any of the conditions to Closing set forth
in Section 3 of this Subscription Agreement are (i) not satisfied or waived prior to the Closing or (ii) not capable of
being satisfied on or prior to the Closing and, in each case of (i) and (ii), as a result thereof, the transactions contemplated
by this Subscription Agreement will not be and are not consummated at the Closing (the termination events described in clauses (a)–(d) above,
collectively, the “Termination Events”); provided that nothing herein will relieve any party from liability
for any willful breach hereof prior to the time of termination, and each party will be entitled to any remedies at law or in equity to
recover losses, liabilities or damages arising from any such willful breach. SPAC shall notify the Investor in writing of the termination
of the Business Combination Agreement promptly after the termination of such agreement. Upon the occurrence of any Termination Event,
this Subscription Agreement shall be void and of no further effect and any monies paid by the Investor to SPAC in connection herewith
shall promptly (and in any event within one (1) business day) following the Termination Event be returned to the Investor.

 

9.            Trust
Account Waiver. The Investor acknowledges that SPAC is a blank check company with the powers and privileges to effect a merger, asset
acquisition, reorganization or similar business combination involving SPAC and one or more businesses or assets. The Investor further
acknowledges that, as described in SPAC’s prospectus relating to its initial public offering dated March 23, 2021 (the “Prospectus”)
available at www.sec.gov, substantially all of SPAC’s assets consist of the cash proceeds of SPAC’s initial public offering
and private placement of its securities, and substantially all of those proceeds have been deposited in a trust account (the “Trust
Account”) for the benefit of SPAC, its public shareholders and the underwriters of SPAC’s initial public offering. Except
with respect to interest earned on the funds held in the Trust Account that may be released to SPAC to pay its tax obligations and to
fund certain of its working capital requirements, the cash in the Trust Account may be disbursed only for the purposes set forth in the
Prospectus. For and in consideration of SPAC entering into this Subscription Agreement, the receipt and sufficiency of which are hereby
acknowledged, the Investor hereby irrevocably waives any and all right, title and interest, or any claim of any kind it has or may have
in the future, in or to any monies held in the Trust Account, and agrees not to seek recourse against the Trust Account as a result of,
or arising out of, this Subscription Agreement; provided, however, that nothing in this Section 9 shall be deemed
to limit the Investor’s right, title, interest or claim to any monies held in the Trust Account by virtue of its record or beneficial
ownership of Shares currently outstanding on the date hereof, pursuant to a validly exercised redemption right with respect to any such
Shares, except to the extent that the Investor has otherwise agreed with SPAC to not exercise such redemption right.

 

    11

     

    

 

Confidential

  

10.            Miscellaneous.

  

a.            Neither
this Subscription Agreement nor any rights that may accrue to the parties hereunder (other than the Shares acquired hereunder, if any)
may be transferred or assigned without the prior written consent of each of the other parties hereto; provided that (i) this Subscription
Agreement and any of the Investor’s rights and obligations hereunder may be assigned to any fund or account managed by the same
investment manager as the Investor or by an affiliate (as defined in Rule 12b-2 of the Exchange Act) of such investment manager
without the prior consent of SPAC and (ii) the Investor’s rights under Section 7 may be assigned to an assignee or transferee
of the Shares following the Closing; provided further that prior to such assignment any such assignee shall agree in writing to be bound
by the terms hereof; provided, that no transfer or assignment pursuant to clause (i) of this Section 10(a) shall relieve
the Investor of its obligations hereunder.

 

b.            SPAC
may request from the Investor such additional information as SPAC may deem necessary to register the resale of the Shares and evaluate
the eligibility of the Investor to acquire the Shares, and the Investor shall promptly provide such information as may reasonably be
requested to the extent readily available; provided that, SPAC agrees to keep any such information provided by Investor confidential
except (i) as necessary to include in any registration statement SPAC is required to file hereunder, (ii) as required by the
federal securities law or pursuant to other routine proceedings of regulatory authorities or (iii) to the extent such disclosure
is required by law, at the request of the staff of the SEC or regulatory agency or under the regulations of any national securities exchange
on which SPAC’s securities are listed for trading. The Investor acknowledges and agrees that if it does not provide SPAC with such
requested information, SPAC may not be able to register the Investor’s Shares for resale pursuant to Section 7 hereof. The
Investor acknowledges that SPAC may file a copy of this Subscription Agreement (or a form of this Subscription Agreement) with the SEC
as an exhibit to a periodic report or a registration statement of SPAC.

 

c.            The
Investor acknowledges that SPAC, FGH, FGMH, IWM, Highlander, the Placement Agent and others will rely on the acknowledgments, understandings,
agreements, representations and warranties contained in this Subscription Agreement, including Schedule A hereto. Prior to the
Closing, the Investor agrees to promptly notify SPAC if any of the acknowledgments, understandings, agreements, representations and warranties
set forth in Section 6 above are no longer accurate in any material respect (other than those acknowledgments, understandings, agreements,
representations and warranties qualified by materiality, in which case the Investor shall notify SPAC if they are no longer accurate
in any respect). The Investor acknowledges and agrees that each purchase by the Investor of Shares from SPAC will constitute a reaffirmation
of the acknowledgments, understandings, agreements, representations and warranties herein (as modified by any such notice) by the Investor
as of the time of such purchase.

 

d.            SPAC,
FGH, FGMH, IWM, Highlander and the Placement Agent are entitled to rely upon this Subscription Agreement and each is irrevocably
authorized to produce this Subscription Agreement or a copy hereof to any interested party in any administrative or legal proceeding
or official inquiry with respect to the matters covered hereby.

 

e.            The
Investor acknowledges and agrees that (a) the Placement Agent is acting solely as a placement agent in connection with the Transaction
and is not acting as an underwriter or in any other capacity and is not and shall not be construed as a fiduciary or financial advisor
for the Investor, SPAC or any other person or entity in connection with the Transaction, (b) the Placement Agent has not made and
will not make any representation or warranty, whether express or implied, of any kind or character and has not provided any advice or
recommendation in connection with the Transaction, (c) the Placement Agent will have no responsibility with respect to (i) any
representations, warranties or agreements made by any person or entity under or in connection with the Transaction or any of the documents
furnished pursuant thereto or in connection therewith, or the execution, legality, validity or enforceability (with respect to any person)
or any thereof, or (ii) the business, condition (financial or otherwise), operations, properties or prospects of, or any other matter
concerning SPAC or the Transaction, (d) the Placement Agent and its respective directors, officers, employees, representatives and
controlling persons have made no independent investigation with respect to any of SPAC or the Shares or the accuracy, completeness or
adequacy of any information supplied to the Investor by SPAC, and (e) the Placement Agent shall have no liability or obligation
(including without limitation, for or with respect to any losses, claims, damages, obligations, penalties, judgments, awards, liabilities,
costs, expenses or disbursements incurred by the Investor, SPAC or any other person or entity), whether in contract, tort or otherwise,
to the Investor, or to any person claiming through the Investor, in respect of the Transaction.

 

    12

     

    

 

Confidential

 

f.            The
Investor waives, to the fullest extent permitted by law, any claims it may have based on any actual or potential conflicts of interest
in connection with the Placement Agent advising or assisting the SPAC with respect to any transaction contemplated by this engagement.
The Investor understands and acknowledges that, in light of the Placement Agent’s role as financial and equity capital markets
advisor to the SPAC, the matters described in any Subscription Agreement and the fees in connection therewith may give rise to potential
conflicts of interest or the appearance thereof. The Investor consents to (and agrees, to the extent applicable and permitted by applicable
law, on behalf of its equity holders, to waive any claims the Investor or its equity holders may have based on any actual or potential
conflicts of interest that may arise or result from) the Placement Agent acting as a financial and equity capital markets advisor to
SPAC and the Placement Agent or one or more of their affiliates engaging in, and receiving any compensation in connection with, any of
the activities described in any Subscription Agreement.

  

g.            All
of the agreements, representations and warranties made by each party hereto in this Subscription Agreement shall survive the Closing.

 

h.            This
Subscription Agreement may not be modified, waived or terminated (other than pursuant to the terms of Section 8 above) except by
an instrument in writing, signed by each of the parties hereto, provided, however, that no modification or waiver by SPAC
of the provisions of this Subscription Agreement shall be effective without the prior written consent of the Shareholders’ Representative
(other than modifications or waivers that are solely ministerial in nature or otherwise immaterial and do not affect any economic or
any other material term of this Subscription Agreement). No failure or delay of either party in exercising any right or remedy hereunder
shall operate as a waiver thereof, nor shall any single or partial exercise of any such right or power, or any abandonment or discontinuance
of steps to enforce such right or power, or any course of conduct, preclude any other or further exercise thereof or the exercise of
any other right or power. The rights and remedies of the parties and the third party beneficiaries hereunder are cumulative and are not
exclusive of any rights or remedies that they would otherwise have hereunder.

 

i.            This
Subscription Agreement (including the schedule hereto) constitutes the entire agreement, and supersedes all other prior agreements, understandings,
representations and warranties, both written and oral, among the parties, with respect to the subject matter hereof. Except as set forth
in this Subscription Agreement with respect to the persons specifically referenced herein (who shall be third party beneficiaries of
and entitled to enforce such provisions), this Subscription Agreement shall not confer any rights or remedies upon any person other than
the parties hereto, and their respective successors and assigns, and the parties hereto acknowledge that such persons so referenced are
third party beneficiaries of this Subscription Agreement with right of enforcement for the purposes of, and to the extent of, the rights
granted to them, if any, pursuant to the applicable provisions; provided, that, notwithstanding anything to the contrary contained in
this Subscription Agreement, the Shareholders’ Representative, FGH, FGMH, IWM and Highlander are intended third party beneficiaries
of each of the provisions of this Subscription Agreement.

 

    13

     

    

 

Confidential

  

j.            Except
as otherwise provided herein, this Subscription Agreement shall be binding upon, and inure to the benefit of the parties hereto and their
heirs, executors, administrators, successors, legal representatives, and permitted assigns, and the agreements, representations, warranties,
covenants and acknowledgments contained herein shall be deemed to be made by, and be binding upon, such heirs, executors, administrators,
successors, legal representatives and permitted assigns.

  

k.            If
any provision of this Subscription Agreement shall be adjudicated by a court of competent jurisdiction to be invalid, illegal or unenforceable,
the validity, legality or enforceability of the remaining provisions of this Subscription Agreement shall not in any way be affected
or impaired thereby and shall continue in full force and effect.

 

l.            This
Subscription Agreement may be executed in one or more counterparts (including by facsimile or electronic mail or in .pdf) and by different
parties in separate counterparts, with the same effect as if all parties hereto had signed the same document. All counterparts so executed
and delivered shall be construed together and shall constitute one and the same agreement.

  

m.            The
parties hereto acknowledge and agree that irreparable damage would occur in the event that any of the provisions of this Subscription
Agreement were not performed in accordance with their specific terms or were otherwise breached. It is accordingly agreed that the parties
shall be entitled to an injunction or injunctions to prevent breaches of this Subscription Agreement, without posting a bond or undertaking
and without proof of damages, to enforce specifically the terms and provisions of this Subscription Agreement, this being in addition
to any other remedy to which such party is entitled at law, in equity, in contract, in tort or otherwise. The parties hereto acknowledge
and agree that the Shareholders’ Representative shall be entitled to specifically enforce the Investor’s obligations to fund
the Subscription Amount and the provisions of the Subscription Agreement of which the Shareholders’ Representative is an express
third party beneficiary, in each case, on the terms and subject to the conditions set forth herein.

  

n.            If
any change in the number, type or classes of authorized shares of SPAC (including the Shares), other than as contemplated by the Business
Combination Agreement or any agreement contemplated by the Business Combination Agreement, shall occur between the date hereof and immediately
prior to the Closing by reason of reclassification, recapitalization, stock split (including reverse stock split) or combination, exchange
or readjustment of shares, or any stock dividend, the number of Shares issued to the Investor shall be appropriately adjusted to reflect
such change.

  

o.            This
Subscription Agreement shall be governed by and construed in accordance with the laws of the State of Delaware (without reference to
its choice of law rules).

 

    14

     

    

 

Confidential

 

p.            Any
dispute, controversy, difference, or claim based on, arising out of or relating to this Subscription Agreement, including its existence,
validity, interpretation, performance, breach, or termination, or any dispute regarding non-contractual obligations arising out of or
relating to this Subscription Agreement (each, a “Proceeding”) shall be referred to and finally resolved by arbitration
in accordance with the Commercial Arbitration Rules of the American Arbitration Association (“AAA”) then in effect
(the “Rules”), except as modified herein, and such arbitration shall be administered by the AAA. The parties agree,
pursuant to Rule R-1(b) of the AAA Rules, that the Expedited Procedures shall apply irrespective of the amount in dispute.
The place of arbitration shall be New York, New York. There shall be one arbitrator who shall be agreed upon by the parties within twenty
(20) days of receipt by respondent of a copy of the demand for arbitration. If any arbitrator is not appointed within the time limit
provided herein, such arbitrator shall be appointed by the AAA in accordance with the listing, striking and ranking procedure in the
Rules, with each party being given a limited number of strikes, except for cause. Any arbitrator appointed by AAA shall be a retired
U.S. judge or a practicing U.S. attorney with no less than fifteen years of experience with corporate and limited partnership matters
and an experienced arbitrator. In rendering an award, the arbitrator shall be required to follow the laws of the state of Delaware. The
award shall be in writing and shall briefly state the findings of fact and conclusions of law on which it is based. The award shall be
final and binding upon the parties and shall be the sole and exclusive remedy between the parties regarding any claims, counterclaims,
issues or accounting presented to the arbitrator. Judgment upon the award may be entered in any court having jurisdiction over any party
or any of its assets, including but not limited to the courts of Hong Kong and the Cayman Islands. Any costs or fees (including attorneys’
fees and expenses) incident to enforcing the award shall be charged against the party resisting such enforcement. All disputes, controversies,
differences, or claims arising out of or relating to this Subscription Agreement, including its existence, validity, interpretation,
performance, breach, or termination, or any dispute regarding non-contractual obligations arising out of or relating to this Subscription
Agreement, shall be resolved in a confidential manner. The arbitrator shall agree to hold any information received during the arbitration
in the strictest of confidence and shall not disclose to any non-party the existence, contents or results of the arbitration or any other
information about such arbitration. The parties to the arbitration shall not disclose any information about the evidence adduced or the
documents produced by the other party in the arbitration proceedings or about the existence, contents or results of the proceeding except
as may be required by law, regulatory or governmental authority or as may be necessary in an action in aid of arbitration or for enforcement
of an arbitral award. Before making any disclosure permitted by the preceding sentence (other than private disclosure to financial regulatory
authorities), the party intending to make such disclosure shall use reasonable efforts to give the other party reasonable written notice
of the intended disclosure and afford the other party a reasonable opportunity to protect its interests. The arbitrator shall determine
what discovery will be permitted, consistent with the goal of reasonably controlling the cost and time that the parties must expend for
discovery; provided that the parties expressly agree that discovery, in the event the arbitrator permits discovery and notwithstanding
the Rules, in connection with any arbitration shall be limited to the following: (i) depositions shall be limited to three (3) depositions
per side, each of which shall be limited to seven (7) hours of testimony taken by each side; (ii) written discovery shall be
limited to one set of Requests for Production per party, limited to no more than fifteen (15) requests, including subparts; (iii) no
interrogatories, requests for admission, or other written discovery shall be permitted; and (iv) the parties shall disclose documents
that they will present in support of their case.  Notwithstanding the foregoing, the arbitrators may grant, upon good cause shown,
either party’s request for discovery in addition to or limiting that for which this paragraph expressly provides. For the avoidance
of doubt, a request by a party to a court of competent jurisdiction for interim measures necessary to preserve such party’s rights,
including pre-arbitration attachments, injunctions, or other equitable relief, shall not be deemed incompatible with, or a waiver of,
the agreement to arbitrate in this Section 10(n).

 

q.            Any
notice or communication required or permitted hereunder to be given to the Investor shall be in writing and either delivered personally,
emailed or sent by overnight mail via a reputable overnight carrier, or sent by certified or registered mail, postage prepaid, to such
address(es) or email address(es) set forth on the signature page hereto, and shall be deemed to be given and received (i) when
so delivered personally, (ii) when sent, with no mail undeliverable or other rejection notice, if sent by email, or (iii) three
(3) business days after the date of mailing to the address below or to such other address or addresses as the Investor may hereafter
designate by notice to SPAC.

 

    15

     

    

 

Confidential

 

11.            Non-Reliance
and Exculpation. The Investor acknowledges that it is not relying upon, and has not relied upon, any statement, representation or
warranty made by any person, other than the statements, representations and warranties of SPAC expressly contained in Section 5
of this Subscription Agreement, in making its investment or decision to invest in SPAC. The Investor acknowledges and agrees that neither
(i) any other investor pursuant to this Subscription Agreement or any other subscription agreement related to the private placement
of the Shares (including the investor’s respective affiliates or any control persons, officers, directors, employees, partners,
agents or representatives of any of the foregoing), nor (ii) any other party to the Business Combination Agreement or any Non-Party
Affiliate (other than SPAC with respect to the previous sentence), including the Placement Agent, its affiliates or any of its or its
affiliates’ respective control persons, officers, directors, employees or other representatives, shall have any liability to the
Investor, or to any other investor, pursuant to, arising out of or relating to this Subscription Agreement or any other subscription
agreement related to the private placement of the Shares, the negotiation hereof or thereof or its subject matter, or the transactions
contemplated hereby or thereby, including, without limitation, with respect to any action heretofore or hereafter taken or omitted to
be taken by any of them in connection with the purchase of the Shares or with respect to any claim (whether in tort, contract or otherwise)
for breach of this Subscription Agreement or in respect of any written or oral representations made or alleged to be made in connection
herewith, as expressly provided herein, or for any actual or alleged inaccuracies, misstatements or omissions with respect to any information
or materials of any kind furnished by or on behalf of SPAC, FGH, FGMH, IWM, Highlander or any Non-Party Affiliate concerning SPAC,
FGH, FGMH, IWM, Highlander or any Non-Party Affiliates, this Subscription Agreement or the transactions contemplated hereby. The
Investor acknowledges that neither the Placement Agent nor its representatives: (a) shall be liable to the Investor for any improper
payment made in accordance with the information provided by SPAC; (b) makes any representation or warranty, or has any responsibilities
as to the validity, accuracy, value or genuineness of any information, certificates or documentation delivered by or on behalf of SPAC
pursuant to this Subscription Agreement or the Business Combination Agreement (together with any related documents, the “Transaction
Documents”) or (c) shall be liable to the Investor (whether in tort, contract or otherwise) (x) for any action taken,
suffered or omitted by any of them in good faith and reasonably believed to be authorized or within the discretion or rights or powers
conferred upon it by this Subscription Agreement or any Transaction Document or (y) for anything which any of them may do or refrain
from doing in connection with this Agreement or any Transaction Document, except for their gross negligence, willful misconduct or bad
faith. For purposes of this Subscription Agreement, “Non-Party Affiliates” means each former, current or future officer,
director, employee, partner, member, manager, direct or indirect equityholder or affiliate of SPAC, FGH, FGMH, IWM, Highlander or
any of SPAC’s, FGH’s, FGMH’s, IWM’s or Highlander’s controlled affiliates or any family member of
the foregoing.

 

12.            Disclosure.
Notwithstanding anything in this Subscription Agreement to the contrary, SPAC shall not publicly disclose the name of the Investor or
any of its affiliates or advisers, or include the name of the Investor or any of its affiliates or advisers in any press release or in
any filing with the SEC or any regulatory agency (including any self-regulatory organization) or trading market, without the prior written
consent of the Investor, except (i) as required by the federal securities law or pursuant to other routine proceedings of regulatory
authorities, (ii) to the extent such disclosure is required by law, at the request of the staff of the SEC or regulatory agency
or under the regulations of any national securities exchange on which SPAC’s securities are listed for trading or (iii) to
the extent such announcements or other communications contain only information previously disclosed in a public statement, press release
or other communication previously approved in accordance with this Section 12.

 

[SIGNATURE PAGES FOLLOW]

 

    16

     

    

 

Confidential

 

IN
WITNESS WHEREOF, the Investor has executed or caused this Subscription Agreement to be executed by its duly authorized representative
as of the date set forth below.

  

	Name of Investor:	 	State/Country of Formation or Domicile:
	 	 	 
	By:		 	 
	Name:		 	 
	Title:		 	 
	 	 	 	 
	Name in which Shares are to be registered
    (if different):	 	Date: ________, 2021
	 	 	 
	Investor’s EIN:	 	 
	 	 	 
	Business Address-Street:	 	Mailing Address-Street (if different):
	 	 	 
	City, State, Zip:	 	City, State, Zip:
	 	 	 
	Attn:		 	Attn:	
	 	 	 	 	 
	Telephone No.:	 	Telephone No.:
	Facsimile No.:	 	Facsimile No.:
	 	 	 
	Number of Shares subscribed for:	 	 
	 	 	 
	Aggregate Subscription Amount: $	 	Price Per Share: $10.00

 

You must pay the Subscription
Amount by wire transfer of United States dollars in immediately available funds to the account specified by SPAC in the Closing Notice.

 

     

     

    

 

Confidential

 

IN WITNESS WHEREOF, SPAC
has accepted this Subscription Agreement as of the date set forth below.

  

	 	MAGNUM OPUS ACQUISITION LIMITED
	 
	 	By:	 
	 	Name:
	 	Title:
	 
	Date:	 

 

     

     

    

 

SCHEDULE A

 

ELIGIBILITY REPRESENTATIONS
OF THE INVESTOR

 

	A.	QUALIFIED INSTITUTIONAL BUYER STATUS
	 	(Please check the applicable subparagraphs):
	 	 
		 ̈ We are a “qualified institutional
                                                                                                          buyer” (as defined in Rule 144A under the Securities Act).

 

	B.	ACCREDITED INVESTOR STATUS
	 	(Please check the applicable
    subparagraphs):

 

	 	1.	 ̈  We
    are an “accredited investor” (within the meaning of Rule 501(a) under the Securities Act or an entity in which
    all of the equity holders are accredited investors within the meaning of Rule 501(a) under the Securities Act), and have
    marked and initialed the appropriate box on the following page indicating the provision under which we qualify as an “accredited
    investor.”
	 	 	 
	 	2.	 ̈  We
    are not a natural person.

 

Rule 501(a), in relevant part, states
that an “accredited investor” shall mean any person who comes within any of the below listed categories, or who the issuer
reasonably believes comes within any of the below listed categories, at the time of the sale of the securities to that person. The Investor
has indicated, by marking and initialing the appropriate box below, the provision(s) below which apply to the Investor and under
which the Investor accordingly qualifies as an “accredited investor.”

 

 ̈  Any
bank, registered broker or dealer, insurance company, registered investment company, business development company, or small business
investment company;

 

 ̈  Any
plan established and maintained by a state, its political subdivisions, or any agency or instrumentality of a state or its political
subdivisions for the benefit of its employees, if such plan has total assets in excess of $5,000,000;

 

 ̈  Any
employee benefit plan, within the meaning of the Employee Retirement Income Security Act of 1974, if a bank, insurance company, or registered
investment adviser makes the investment decisions, or if the plan has total assets in excess of $5,000,000;

  

 ̈  Any
organization described in Section 501(c)(3) of the Internal Revenue Code, corporation, limited liability company, similar business
trust, or partnership, not formed for the specific purpose of acquiring the securities offered, with total assets in excess of $5,000,000;

 

 ̈  Any
trust with assets in excess of $5,000,000, not formed to acquire the securities offered, whose purchase is directed by a sophisticated
person;

  

 ̈  Any
 “family office,” as defined in rule 202(a)(11)(g)-1 under the Investment Advisers Act of 1940, as amended, with assets
under management in excess of $5,000,000, not formed to acquire the securities offered, and whose prospective investment is directed
by a person who has such knowledge and experience in financial and business matters that such family office is capable of evaluating
the merits and risks of the prospective investment;

 

 ̈  Any
 “family client,” as defined in rule 202(a)(11)(G)-1 under the Investment Advisers Act of 1940 (17 CFR 275.202(a)(11)(G)-1)),
of a family office meeting the requirements in paragraph (a)(12) of this section and whose prospective investment in the issuer is directed
by such family office pursuant to paragraph (a)(12)(iii).

 

     

     

    

 

 ̈  Any
director, executive officer, or general partner of the issuer of the securities being offered or sold, or any director, executive officer,
or general partner of a general partner of that issuer;

  

 ̈  Any
natural person whose individual net worth, or joint net worth with that person’s spouse, exceeds $1,000,000. For purposes of calculating
a natural person’s net worth: (a) the person’s primary residence shall not be included as an asset; (b) indebtedness
that is secured by the person’s primary residence, up to the estimated fair market value of the primary residence at the time of
the sale of securities, shall not be included as a liability (except that if the amount of such indebtedness outstanding at the time
of sale of securities exceeds the amount outstanding sixty (60) days before such time, other than as a result of the acquisition of the
primary residence, the amount of such excess shall be included as a liability); and (c) indebtedness that is secured by the
person’s primary residence in excess of the estimated fair market value of the primary residence at the time of the sale of securities
shall be included as a liability;

 

 ̈  Any
natural person who had an individual income in excess of $200,000 in each of the two most recent years or joint income with that person’s
spouse in excess of $300,000 in each of those years and has a reasonable expectation of reaching the same income level in the current
year;

 

 ̈  Any
natural person holding in good standing one or more professional certifications or designations or credentials from an accredited educational
institution that the SEC has designated as qualifying an individual for accredited investor status; or

 

 ̈  Any
entity in which all of the equity owners are accredited investors meeting one or more of the above tests.

  

This page should
be completed by the Investor

and constitutes
a part of the Subscription Agreement.Exhibit 10.2

 

EXECUTION VERSION

Confidential

 

SUPPORT AGREEMENT

 

This
SUPPORT AGREEMENT (this “Agreement”) is made and entered into as of August 26, 2021, by and among Integrated
Whale Media Investment, Inc., a BVI business company incorporated in the British Virgin Islands (“IWM”
or the “Shareholders’ Representative”), Magnum Opus Acquisition Limited, an exempted company incorporated
in the Cayman Islands with limited liability (“Purchaser”), and the shareholders of Purchaser set forth on
Schedule A hereto (each a “Purchaser Shareholder”).

 

WHEREAS,
Purchaser, IWM, in its capacity as a seller and as the Shareholders’ Representative, Highlander Management LLC, a limited
liability company incorporated in the State of Delaware (“Highlander”), Forbes Global Holdings Inc., a BVI
business company incorporated in the British Virgin Islands (“FGH”) and Forbes Global Media Holdings, Inc.,
a BVI business company incorporated in the British Virgin Islands (the “Company”) are concurrently herewith
entering into a Business Combination Agreement (as the same may be amended, restated or supplemented, the “Business Combination
Agreement”; capitalized terms used but not defined herein shall have the meaning ascribed to such terms in the Business
Combination Agreement) pursuant to which, among other things, Purchaser will acquire 100% of the issued share capital of FGH from IWM
and 5% of the issued share capital of the Company from Highlander, on the terms and subject to the conditions therein;

 

WHEREAS,
each Purchaser Shareholder is, as of the date of this Agreement, beneficial and the sole legal owner of the number of Class B ordinary
shares of Purchaser (“Purchaser Class B Shares” and, together with the Purchaser Ordinary Shares, the
 “Purchaser Shares”) set forth opposite such Purchaser Shareholder’s name on Schedule A hereto
(such Purchaser Class B Shares, together with any other Purchaser Shares acquired by such Purchaser Shareholder after the date of
this Agreement and during the term of this Agreement, being collectively referred to herein as the “Subject Shares”);
and

 

WHEREAS,
Magnum Opus Holdings LLC, a Cayman Islands limited liability company (“Sponsor”) is, as of the date of this
Agreement, beneficial and the sole legal owner of the number of warrants entitling the holder thereof to purchase one Purchaser Ordinary
Share at a price of  $11.50 per share (“Purchaser Warrants”) set forth opposite Sponsor’s name
on Schedule A hereto (such Purchaser Warrants, the “Subject Warrants”);

 

WHEREAS,
as a condition to their willingness to enter into the Business Combination Agreement, Purchaser and the Shareholders’ Representative
have requested that each Purchaser Shareholder enter into this Agreement.

 

NOW, THEREFORE, the parties hereto agree as follows:

 

Article I

Representations and Warranties of Purchaser Shareholder

 

Each Purchaser Shareholder hereby represents and
warrants (except for with respect to representations and warranties which are designated as “with respect to Sponsor only”,
with respect to which only Sponsor hereby represents and warrants) to Purchaser and the Shareholders’ Representative:

 

1.1            Incorporation
and Power.   With respect to Sponsor only, (i) it is a limited liability company incorporated, validly existing and
in good standing under the laws of the Cayman Islands, and has all requisite corporate power and authority and all authorizations, licenses
and permits necessary to own, lease and operate its properties and to carry on its businesses as now conducted, and (ii) it is not
in breach of Sponsor’s Organizational Documents.

 

    1

     

    

 

1.2            Authorization;
No Breach; Valid and Binding Agreement.

 

(a)            With
respect to Sponsor only, it has all requisite corporation or limited liability company power and authority to execute and deliver this
Agreement, to perform its obligations hereunder and to consummate the transactions contemplated hereby. The execution, delivery and performance
of this Agreement by Sponsor and the consummation of the transactions contemplated hereby have been duly and validly authorized by all
requisite corporate action on the part of Sponsor, and no other corporate actions or proceedings on the part of Sponsor are necessary
to authorize the execution, delivery or performance of this Agreement or to consummate the transactions contemplated hereby. If such
Purchaser Shareholder is a natural person, such Purchaser Shareholder has full legal capacity, right and authority to execute and deliver
this Agreement, to perform his or her obligations hereunder and to consummate the transactions contemplated hereby.

 

(b)            The
execution, delivery and performance of this Agreement by such Purchaser Shareholder and the consummation of the transactions contemplated
hereby do not and will not conflict with or result in any breach of, constitute a default (or an event that, with or without notice or
lapse of time or both, would become a default) under, result in a violation of, result in the creation of any Lien upon any assets or
properties of such Purchaser Shareholder under, give rise to any right of payment, penalty, modification, amendment or termination, cancellation
or acceleration with respect to, or loss or impairment of any right under, or require any authorization, consent, approval, exemption
or other action by, notice to or filing with any court or other Governmental Authority under (i) the provisions of Sponsor’s
Organizational Documents (with respect to Sponsor only), (ii) any Contract or instrument or Permit to which such Purchaser Shareholder
or its, his or her properties or assets is bound, or (iii) any Law, statute, rule or regulation or order, judgment or decree
to which such Purchaser Shareholder is subject or its or their respective properties or assets are subject; except, with respect to clause
(ii) or (iii) of this Section 1.2(b), where the failure to obtain such authorization, consent, approval or exemption would
not, individually or in the aggregate, prevent, materially impair or materially delay such Purchaser Shareholder from consummating the
transaction contemplated hereby.

 

(c)            This
Agreement has been duly executed and delivered by such Purchaser Shareholder, and assuming that this Agreement is a valid and binding
obligation of the other parties hereto, this Agreement constitutes a valid and binding obligation of such Purchaser Shareholder, enforceable
in accordance with its terms, except as enforceability may be limited by bankruptcy laws, other similar Laws affecting creditors’
rights and general principles of equity affecting the availability of specific performance and other equitable remedies.

 

1.3            Subject
Shares. Such Purchaser Shareholder is beneficial and sole legal owner of the Purchaser Shares and Purchaser Warrants (as applicable)
set forth opposite such Purchaser Shareholder’s name on Schedule A hereto, and all such Subject Shares and Subject Warrants
(as applicable) are owned by such Purchaser Shareholder free and clear of all liens or encumbrances, other than liens or encumbrances
pursuant to this Agreement, the Purchaser’s Organizational Documents or applicable federal or state securities laws. Such Purchaser
Shareholder does not legally own any shares or other equity securities or securities convertible, exercisable or exchangeable into equity
securities of Purchaser other than the Subject Shares and the Subject Warrants (as applicable). Such Purchaser Shareholder has the sole
right to vote the Subject Shares, and none of the Subject Shares is subject to any voting trust or other agreement, arrangement or restriction
with respect to the voting of the Subject Shares, except as contemplated by this Agreement, any other Ancillary Agreement or Purchaser’s
Organizational Documents.

 

    2

     

    

 

1.4            Orders.
There is no Governmental Order pending or, to the knowledge of each Purchaser Shareholder, threatened in writing, by or against a Purchaser
Shareholder, that seeks to delay or prevent the performance by a Purchaser Shareholder of its obligations under this Agreement.

 

1.5            Brokerage
Fees.   With respect to Sponsor only, except as described on Section 5.18 of the Purchaser Disclosure Letter, no broker,
finder, investment banker or other Person is entitled to any brokerage fee, finders’ fee or other commission in connection with
the transactions contemplated by the Business Combination Agreement based upon arrangements made by Sponsor, for which Purchaser or any
of its Affiliates may become liable.
 

1.7            Affiliate
Arrangements. Except as set forth on Schedule A attached hereto, no Purchaser Shareholder, any Affiliate of any Purchaser
Shareholder, nor anyone related by blood, marriage or adoption to a Purchaser Shareholder or any such Affiliate, is party to, or has
any rights with respect to or arising from, any Contract with Purchaser or its Subsidiaries, other than as contemplated by the Business
Combination Agreement, any Ancillary Agreement or in connection with the Transactions or as set forth in the Purchaser SEC Reports.

 

1.8            Acknowledgement.
Such Purchaser Shareholder understands and acknowledges that each of Purchaser and the Shareholders’ Representative is entering
into the Business Combination Agreement in reliance upon such Purchaser Shareholder’s execution and delivery of this Agreement.

 

Article II

Representations and Warranties of Purchaser

 

Purchaser hereby represents and warrants to each
Purchaser Shareholder and the Shareholders’ Representative:

 

2.1            Incorporation
and Power. Purchaser is an exempted company incorporated with limited liability, validly existing and in good standing under the
laws of the Cayman Islands, and has all requisite corporate power and authority and all authorizations, licenses and permits necessary
to own, lease and operate its properties and to carry on its businesses as now conducted. Purchaser is not in breach of Purchaser’s
Organizational Documents.

 

2.2            Authorization;
No Breach; Valid and Binding Agreement.

 

(a)            Purchaser
has all requisite corporation or limited liability company power and authority to execute and deliver this Agreement, to perform its
obligations hereunder and to consummate the transactions contemplated hereby. The execution, delivery and performance of this Agreement
by Purchaser and the consummation of the transactions contemplated hereby have been duly and validly authorized by all requisite corporate
action on the part of Purchaser, and no other corporate actions or proceedings on the part of Purchaser are necessary to authorize the
execution, delivery or performance of this Agreement or to consummate the transactions contemplated hereby.

 

(b)            The
execution, delivery and performance of this Agreement by Purchaser and the consummation of the transactions contemplated hereby do not
and will not conflict with or result in any breach of, constitute a default (or an event that, with or without notice or lapse of time
or both, would become a default) under, result in a violation of, result in the creation of any Lien upon any assets or properties of
Purchaser under, give rise to any right of payment, penalty, modification, amendment or termination, cancellation or acceleration with
respect to, or loss or impairment of any right under, or require any authorization, consent, approval, exemption or other action by,
notice to or filing with any court or other Governmental Authority under (i) the provisions of Purchaser’s Organizational
Documents, (ii) any Contract or instrument or Permit to which Purchaser or its properties or assets is bound, or (iii) any
Law, statute, rule or regulation or order, judgment or decree to which Purchaser is subject or its or their respective properties
or assets are subject; except, with respect to clause (ii) or (iii) of this Section 2.2(b), where the failure to obtain
such authorization, consent, approval or exemption would not, individually or in the aggregate, prevent, materially impair or materially
delay Purchaser from consummating the transaction contemplated hereby.

 

    3

     

    

 

(c)            This
Agreement has been duly executed and delivered by Purchaser, and assuming that this Agreement is a valid and binding obligation of the
other parties hereto, this Agreement constitutes a valid and binding obligation of Purchaser, enforceable in accordance with its terms,
except as enforceability may be limited by bankruptcy laws, other similar Laws affecting creditors’ rights and general principles
of equity affecting the availability of specific performance and other equitable remedies.

 

Article III

Representations and Warranties of the Shareholders’ Representative

 

The
Shareholders’ Representative hereby represents and warrants to each Purchaser Shareholder and Purchaser:

 

3.1            Incorporation
and Power. The Shareholders’ Representative is a BVI business company incorporated, validly existing and in good standing under
the laws of the British Virgin Islands, and has all requisite corporate power and authority and all authorizations, licenses and permits
necessary to own, lease and operate its properties and to carry on its businesses as now conducted. The Shareholders’ Representative
is not in breach of Organizational Documents of the Shareholders’ Representative.

 

3.2            Authorization;
No Breach; Valid and Binding Agreement.

 

(a)            The
Shareholders’ Representative has all requisite corporation or limited liability company power and authority to execute and deliver
this Agreement, to perform its obligations hereunder and to consummate the transactions contemplated hereby. The execution, delivery
and performance of this Agreement by the Shareholders’ Representative and the consummation of the transactions contemplated hereby
have been duly and validly authorized by all requisite corporate action on the part of the Shareholders’ Representative, and no
other corporate actions or proceedings on the part of the Shareholders’ Representative are necessary to authorize the execution,
delivery or performance of this Agreement or to consummate the transactions contemplated hereby.

 

(b)            The
execution, delivery and performance of this Agreement by the Shareholders’ Representative and the consummation of the transactions
contemplated hereby do not and will not conflict with or result in any breach of, constitute a default (or an event that, with or without
notice or lapse of time or both, would become a default) under, result in a violation of, result in the creation of any Lien upon any
assets or properties of the Shareholders’ Representative under, give rise to any right of payment, penalty, modification, amendment
or termination, cancellation or acceleration with respect to, or loss or impairment of any right under, or require any authorization,
consent, approval, exemption or other action by, notice to or filing with any court or other Governmental Authority under (i) the
provisions of Organizational Documents of the Shareholders’ Representative, (ii) any Contract or instrument or Permit to which
the Shareholders’ Representative or its or their respective properties or assets is bound, or (iii) any Law, statute, rule or
regulation or order, judgment or decree to which the Shareholders’ Representative is subject or its properties or assets are subject;
except, with respect to clause (ii) or (iii) of this Section 3.2(b), where the failure to obtain such authorization, consent,
approval or exemption would not, individually or in the aggregate, prevent, materially impair or materially delay the Shareholders’
Representative from consummating the transaction contemplated hereby.

 

    4

     

    

 

(c)            This
Agreement has been duly executed and delivered by the Shareholders’ Representative, and assuming that this Agreement is a valid
and binding obligation of the other parties hereto, this Agreement constitutes a valid and binding obligation of the Shareholders’
Representative, enforceable in accordance with its terms, except as enforceability may be limited by bankruptcy laws, other similar Laws
affecting creditors’ rights and general principles of equity affecting the availability of specific performance and other equitable
remedies.

 

3.3
            Orders.  
There is no Governmental Order pending or, to the knowledge of the Shareholders’ Representative, threatened in writing, by or against
the Shareholders’ Representative, that seeks to delay or prevent the performance by the Shareholders’ Representative of its
obligations under this Agreement.

 

Article IV

Support Agreement; Certain Other Covenants of Purchaser Shareholder

 

4.1            Binding
Effect of Business Combination Agreement. Sponsor hereby acknowledges that it has read the Business Combination Agreement and Sponsor
has had the opportunity to consult with its tax and legal advisors. Sponsor shall be bound by and comply with the obligations of Purchaser
pursuant to Section 6.04(b) (Confidentiality, Public Announcements) and Section 6.21 (Acquisition Proposals
and Alternative Transactions) of the Business Combination Agreement (and any relevant definitions contained in such Sections) as
if Sponsor was an original signatory to the Business Combination Agreement with respect to such provisions.

 

4.2            Agreement
to Vote.

 

(a)            In
Favor of the Transactions. At any general meeting of Purchaser called to seek the Purchaser Shareholder Approval, or at any adjournment
thereof, or in connection with any shareholder written resolution of Purchaser or in any other circumstances upon which a vote, consent,
resolution or other approval with respect to the Business Combination Agreement, the Ancillary Agreements, or any Transaction is sought,
such Purchaser Shareholder shall, (i) if a meeting is held, appear at such meeting or otherwise cause the Subject Shares to be counted
as present at such meeting for purposes of establishing a quorum, and (ii) vote or cause to be voted (including by class vote and/or
shareholder written consent or written resolution, if applicable) the Subject Shares in favor of granting the Purchaser Shareholder Approval
or, if there are insufficient votes in favor of granting the Purchaser Shareholder Approval, in favor of the adjournment of such general
meeting of Purchaser to a later date.

 

    5

     

    

 

(b)            Against
Other Transactions. At any general meeting of Purchaser, or at any adjournment thereof, or in connection with any shareholder written
resolution of Purchaser or in any other circumstances upon which such Purchaser Shareholder’s vote, consent, resolution or other
approval is sought, such Purchaser Shareholder shall vote (or cause to be voted) the Subject Shares (including by withholding class vote
and/or written consent or written resolution, if applicable) against (i) any business combination agreement, merger agreement or
merger (other than the Business Combination Agreement and the Transactions), scheme of arrangement, business combination, consolidation,
combination, sale of substantial assets, reorganization, recapitalization, dissolution, liquidation or winding up of or by Purchaser
or any public offering of any shares of Purchaser, any of its Subsidiaries, or a newly-formed holding company of Purchaser or such Subsidiaries,
other than in connection with the Transactions in accordance with the terms of the Business Combination Agreement, (ii) any inquiry,
proposal or offer, or any indication of interest in making an offer or proposal, from any Person or group at any time relating to a Business
Combination for Purchaser other than the Transactions, (iii) any change in the business, management or board of directors of Purchaser
(other than in connection with the Transactions and the Purchaser Shareholder Proposals), (iv) other than any amendment to the Organizational
Documents of Purchaser contemplated in the Business Combination Agreement, any amendment of the Organizational Documents of Purchaser
or other proposal or transaction involving Purchaser or any of its Subsidiaries, or (v) any other action, proposal or agreement
that would be reasonably likely to (A) prevent, impede, interfere with, delay, postpone or attempt to discourage, adversely affect,
frustrate the purposes of, result in a breach by Purchaser of, prevent or nullify any provision of the Business Combination Agreement
or any Ancillary Agreement, or any Transaction or change in any manner the voting rights of any class of Purchaser’s share capital,
(B) result in a breach in any respect of any covenant, representation, warranty or any other obligation or agreement of Purchaser
under the Business Combination Agreement or any Ancillary Agreement, (C) result in any of the conditions set forth in Article VII
of the Business Combination Agreement not being fulfilled or (D) change in any manner the dividend policy or capitalization of,
any class of capital stock of, Purchaser.

 

(c)            Revoke
Other Proxies. Such Purchaser Shareholder represents and covenants that any proxies or agreements heretofore given in respect of
the Subject Shares that may still be in effect are not irrevocable, and such proxies or agreements have been or are hereby revoked.

 

4.3            Sponsor
Letter Agreement No Purchaser Shareholder shall modify or amend that certain Letter Agreement, dated as of March 23, 2021, by
and among the Purchaser Shareholders and Purchaser (the “Sponsor Letter Agreement”), other than as contemplated
by the Business Combination Agreement, any Ancillary Agreement or in connection with the Transactions.

 

4.4            Purchaser
Contracts. No Purchaser Shareholder shall enter into, renew or amend in any material respect, any transaction or Contract between
or among Purchaser Shareholder, any Affiliate of Purchaser Shareholder, or anyone related by blood, marriage or adoption to Purchaser
Shareholder or any Affiliate of Purchaser Shareholder (other than Purchaser or any of its Subsidiaries), on the one hand, and Purchaser
or any of Purchaser’s Subsidiaries, on the other hand, other than as contemplated by the Business Combination Agreement, any Ancillary
Agreement or in connection with the Transactions.

 

    6

     

    

 

4.5            No
Transfer. Other than (x) pursuant to this Agreement, (y) upon the consent of the Shareholders’ Representative or
(z) to an Affiliate of such Purchaser Shareholder (provided that such Affiliate shall enter into a written agreement, in form and
substance reasonably satisfactory to Purchaser, agreeing to be bound by this Agreement to the same extent as such Purchaser Shareholder
was with respect to such transferred Subject Shares or Subject Warrants, as applicable), from the date of this Agreement until the date
of termination of this Agreement, such Purchaser Shareholder shall not, directly or indirectly, (i) (a) sell, offer to sell,
contract or agree to sell, hypothecate, pledge, mortgage, grant any option, right or warrant to purchase or otherwise transfer, dispose
of or agree to transfer or dispose of, directly or indirectly, or establish or increase a put equivalent position or liquidate or decrease
a call equivalent position within the meaning of Section 16 of the Exchange Act, and the rules and regulations of the Securities
and Exchange Commission promulgated thereunder, any Subject Share or Subject Warrant, as applicable, (b) enter into any swap or
other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of any Subject Shares
or Subject Warrants, as applicable, whether any such transaction is to be settled by delivery of such securities, in cash or otherwise,
or (c) publicly announce any intention to effect any transaction specified in clause (a) or (b) (the actions specified
in clauses (a)-(c), collectively, “Transfer”), other than set forth in this Agreement or any other Ancillary
Agreement, (ii) grant any proxies or enter into any voting arrangement, whether by proxy, voting agreement, voting trust, voting
deed or otherwise (including pursuant to any loan of Subject Shares), or enter into any other agreement, with respect to any Subject
Shares, in each case, other than as set forth in this Agreement or any other Ancillary Agreement, (iii) take any action that would
make any representation or warranty of such Purchaser Shareholder herein untrue or incorrect, or have the effect of preventing or disabling
such Purchaser Shareholder from performing its obligations hereunder, or (iv) commit or agree to take any of the foregoing actions
or take any other action or enter into any Contract that would reasonably be expected to make any of its representations or warranties
contained herein untrue or incorrect or would have the effect of preventing or delaying such Purchaser Shareholder from performing any
of its obligations hereunder. Any action attempted to be taken in violation of the preceding sentence will be null and void. Such Purchaser
Shareholder agrees with, and covenants to, Purchaser and the Shareholders’ Representative that such Purchaser Shareholder shall
not request that Purchaser register the Transfer (by book-entry or otherwise) of any certificated or uncertificated interest representing
any of the Subject Shares or Subject Warrants, as applicable.

 

4.6            Waiver
of Anti-Dilution Protection. Such Purchaser Shareholder hereby waives, forfeits, surrenders and agrees not to exercise, assert or
claim, to the fullest extent permitted by applicable Law, the ability to adjust the Initial Conversion Ratio (as defined in the Purchaser’s
amended and restated memorandum and articles of association adopted by special resolution on March 22, 2021 and effective on March 22,
2021 (the “Purchaser Charter”)) pursuant to Article 17.3 of the Purchaser Charter in connection with the
Transactions, and any rights to other anti-dilution protections with respect to Purchaser Shares that may result from the PIPE Investment
and/or the consummation of the Transactions. Such Purchaser Shareholder acknowledges and agrees that (i) this Section 4.6 shall
constitute written consent waiving, forfeiting and surrendering the adjustment to the Initial Conversion Ratio pursuant to Article 17.4
of the Purchaser Charter; and (ii) such waiver, forfeiture and surrender granted hereunder shall only terminate upon the termination
of the Business Combination Agreement.

 

4.7            No
Redemption. Such Purchaser Shareholder irrevocably and unconditionally agrees that, from the date hereof and until the termination
of this Agreement, such Purchaser Shareholder shall not elect to have any Subject Shares redeemed now or at any time legally or beneficially
owned by such Purchaser Shareholder, or submit or surrender any of its Subject Shares for redemption, in connection with the Transactions
or otherwise.

 

4.8            New
Shares. In the event that prior to the Closing (i) any Purchaser Shares, Purchaser Warrants or other securities are issued or
otherwise distributed to such Purchaser Shareholder pursuant to any stock dividend or distribution, or any change in any of the Purchaser
Shares, Purchaser Warrants or other share capital of Purchaser by reason of any stock split-up, recapitalization, combination, exchange
of shares or the like, (ii) such Purchaser Shareholder acquires legal or beneficial ownership of any Purchaser Shares or Purchaser
Warrants after the date of this Agreement, including upon exercise of options or settlement of restricted share units or (iii) such
Purchaser Shareholder acquires the right to vote or share in the voting of any Purchaser Share after the date of this Agreement (collectively,
the “New Securities”), the terms “Subject Shares” and “Subject Warrants”, as applicable,
shall be deemed to refer to and include such New Securities (including all such stock dividends and distributions and any securities
into which or for which any or all of the Subject Shares may be changed or exchanged into) and be subject to the terms of this Agreement
to the same extent as if they constituted the Subject Shares or Subject Warrants owned by such Purchaser Shareholder as of the date hereof.

 

    7

     

    

 

4.9            Fiduciary
Duties. Notwithstanding anything in this Agreement to the contrary, (i) such Purchaser Shareholder makes no agreement or understanding
herein in any capacity other than in its, his or her capacity as a record holder and beneficial owner of the Subject Shares, and (ii) nothing
herein will be construed to limit or affect any action or inaction by any representative of such Purchaser Shareholder serving as a member
of the board of directors (or other similar governing body) of Purchaser or as an officer, employee or fiduciary of Purchaser, in each
case, acting in such person’s capacity as a director, officer, employee or fiduciary of Purchaser.

 

4.10            Termination.
This Agreement shall terminate upon the earliest of (i) the Closing (provided, however, that upon such termination,
Section 4.1 (with respect to obligations pursuant to Section 6.04(b) (Confidentiality, Public Announcements) of
the Business Combination Agreement only), Section 4.6, Section 4.9, this Section 4.10 and Article V shall survive
indefinitely) and (ii) the termination of the Business Combination Agreement in accordance with its terms (provided, however,
that upon such termination, Section 4.9, this Section 4.10 and Article V shall survive indefinitely).

 

4.11            Additional
Matters. Such Purchaser Shareholder shall take, or cause to be taken, all actions and do, or cause to be done, all things reasonably
necessary under applicable Laws to consummate the Share Sale and the other Transactions contemplated by the Business Combination Agreement
on the terms and subject to the conditions set forth therein and herein. Such Purchaser Shareholder shall, from time to time, (i) execute
and deliver, or cause to be executed and delivered, such additional or further consents, documents and other instruments as Purchaser
or the Shareholders’ Representative may reasonably request for the purpose of effectively carrying out the transactions contemplated
by this Agreement, the Business Combination Agreement and any other Ancillary Agreement, including the Investor Rights Agreement (with
respect to Sponsor only) and (ii) refrain from exercising any veto right, consent right or similar right (whether under the Organizational
Documents of Purchaser or the Cayman Act) which would impede, disrupt, prevent or otherwise adversely affect the consummation of any
Transaction.

 

Article V

General Provisions.

 

5.1            Notice.
All notices and other communications hereunder shall be in writing and shall be deemed given if delivered personally or sent by overnight
courier (providing proof of delivery) to Purchaser and the Shareholders’ Representative in accordance with Section 10.06 of
the Business Combination Agreement and to each Purchaser Shareholder at its, his or her address set forth set forth on Schedule A
hereto (or at such other address for a party as shall be specified by like notice). Sections 8 and 19(3) of the Electronic Transactions
Act (As Revised) of the Cayman Islands shall not apply.

 

5.2            Remedies;
Specific Performance.   The parties hereto acknowledge that money damages would not be an adequate remedy at law if any party fails
to perform any of its obligations hereunder and accordingly agree that each party, in addition to any other remedy to which it may be
entitled at law or in equity, shall be entitled to an injunction or similar equitable relief restraining such party from committing or
continuing any such breach or threatened breach and to compel specific performance of the obligations of any other party under this Agreement,
without the posting of any bond. If any action should be brought in equity to enforce any of the provisions of this Agreement, none of
the parties shall raise the defense that there is an adequate remedy at law. No remedy shall be exclusive of any other remedy, and all
available remedies shall be cumulative.

 

5.3            Governing
Law.   This Agreement shall be governed by and construed in accordance with the laws of the State of Delaware (without
reference to its choice of law rules).

 

    8

     

    

 

5.4            Binding
Arbitration. Any dispute, controversy, difference, or claim based on, arising out of or relating to this Agreement, including its
existence, validity, interpretation, performance, breach, or termination, or any dispute regarding non-contractual obligations arising
out of or relating to this Agreement (each, a “Proceeding”) shall be referred to and finally resolved by arbitration
in accordance with the Commercial Arbitration Rules of the American Arbitration Association (“AAA”) then
in effect (the “Rules”), except as modified herein, and such arbitration shall be administered by the AAA.
The parties agree, pursuant to Rule R-1(b) of the AAA Rules, that the Expedited Procedures shall apply irrespective of the
amount in dispute. The place of arbitration shall be New York, New York. There shall be one arbitrator who shall be agreed upon by the
parties within twenty (20) days of receipt by respondent of a copy of the demand for arbitration. If any arbitrator is not appointed
within the time limit provided herein, such arbitrator shall be appointed by the AAA in accordance with the listing, striking and ranking
procedure in the Rules, with each party being given a limited number of strikes, except for cause. Any arbitrator appointed by AAA shall
be a retired U.S. judge or a practicing U.S. attorney with no less than fifteen years of experience with corporate and limited partnership
matters and an experienced arbitrator. In rendering an award, the arbitrator shall be required to follow the laws of the state of Delaware.
The award shall be in writing and shall briefly state the findings of fact and conclusions of law on which it is based. The award shall
be final and binding upon the parties and shall be the sole and exclusive remedy between the parties regarding any claims, counterclaims,
issues or accounting presented to the arbitrator. Judgment upon the award may be entered in any court having jurisdiction over any party
or any of its assets, including but not limited to the courts of Hong Kong and the Cayman Islands. Any costs or fees (including attorneys’
fees and expenses) incident to enforcing the award shall be charged against the party resisting such enforcement. All disputes, controversies,
differences, or claims arising out of or relating to this Agreement, including its existence, validity, interpretation, performance,
breach, or termination, or any dispute regarding non-contractual obligations arising out of or relating to this Agreement, shall be resolved
in a confidential manner. The arbitrator shall agree to hold any information received during the arbitration in the strictest of confidence
and shall not disclose to any non-party the existence, contents or results of the arbitration or any other information about such arbitration.
The parties to the arbitration shall not disclose any information about the evidence adduced or the documents produced by the other party
in the arbitration proceedings or about the existence, contents or results of the proceeding except as may be required by law, regulatory
or governmental authority or as may be necessary in an action in aid of arbitration or for enforcement of an arbitral award. Before making
any disclosure permitted by the preceding sentence (other than private disclosure to financial regulatory authorities), the party intending
to make such disclosure shall use reasonable efforts to give the other party reasonable written notice of the intended disclosure and
afford the other party a reasonable opportunity to protect its interests. The arbitrator shall determine what discovery will be permitted,
consistent with the goal of reasonably controlling the cost and time that the parties must expend for discovery; provided that the parties
expressly agree that discovery, in the event the arbitrator permits discovery and notwithstanding the Rules, in connection with any arbitration
shall be limited to the following: (i) depositions shall be limited to three (3) depositions per side, each of which shall
be limited to seven (7) hours of testimony taken by each side; (ii) written discovery shall be limited to one set of Requests
for Production per party, limited to no more than fifteen (15) requests, including subparts; (iii) no interrogatories, requests
for admission, or other written discovery shall be permitted; and (iv) the Parties shall disclose documents that they will present
in support of their case. Notwithstanding the foregoing, the arbitrators may grant, upon good cause shown, either party’s request
for discovery in addition to or limiting that for which this paragraph expressly provides. For the avoidance of doubt, a request by a
party to a court of competent jurisdiction for interim measures necessary to preserve such party’s rights, including pre-arbitration
attachments, injunctions, or other equitable relief, shall not be deemed incompatible with, or a waiver of, the agreement to arbitrate
in this Section 5.4.

 

5.5            Assignment.
This Agreement and all of the provisions hereof will be binding upon and inure to the benefit of the parties hereto and their respective
heirs, successors and permitted assigns. Neither this Agreement nor any of the rights, interests or obligations hereunder will be assigned
(including by operation of law) without the prior written consent of the parties hereto.

 

    9

     

    

 

5.6            Amendment.
This Agreement may not be amended, changed, supplemented, waived or otherwise modified or terminated, except upon the execution and delivery
of a written agreement executed by each Purchaser Shareholder, Purchaser and the Shareholders’ Representative.

 

5.7            Severability.
If any provision of this Agreement is held invalid or unenforceable by any court of competent jurisdiction, the other provisions of this
Agreement will remain in full force and effect. Any provision of this Agreement held invalid or unenforceable only in part or degree
will remain in full force and effect to the extent not held invalid or unenforceable.

 

5.8            Counterparts.
This Agreement may be executed in two or more counterparts (any of which may be delivered by electronic transmission), each of which
shall constitute an original, and all of which taken together shall constitute one and the same instrument. Delivery by email to counsel
for the other parties of a counterpart executed by a party shall be deemed to meet the requirements of the previous sentence.

 

5.9            Entire
Agreement. This Agreement and the agreements referenced herein constitute the entire agreement and understanding of the parties hereto
in respect of the subject matter hereof and supersede all prior understandings, agreements or representations by or among the parties
hereto to the extent they relate in any way to the subject matter hereof.

 

[Signature pages follow]

 

    10

     

    

 

IN WITNESS WHEREOF, each party has duly executed this Agreement, all
as of the date first written above.

 

	Magnum Opus Holdings LLC:	 
	 	 	 
	Signature:	 /s/ Hou Pu Jonathan Lin	 
	 	 	 
	Name:	 Hou Pu Jonathan Lin	 
	 	 	 
	Title:	 Manager	 

 

	 /s/ Hou Pu Jonathan Lin	 
	Hou Pu Jonathan Lin	 
	 	 
	 /s/ Ka Man Kevin Lee	 
	Ka Man Kevin Lee	 
	 	 
	 /s/ Frank Han	 
	Frank Han	 
	 	 
	 /s/ Alexandre Mathieu Valdemar Casin	 
	Alexandre Mathieu Valdemar Casin	 
	 	 
	 /s/ Liu Xing Ling	 
	Liu Xing Ling	 
	 	 
	 /s/ Wing Hong Sammy Hsieh	 
	Wing Hong Sammy Hsieh	 
	 	 
	 /s/ Dickson Cheng	 
	Dickson Cheng	 
	 	 
	 /s/ Tung Wai Hui	 
	Tung Wai Hui	 

 

     

     

    

 

IN WITNESS WHEREOF, each party has duly executed this Agreement, all
as of the date first written above.

 

	Magnum Opus Acquisition Limited	 
	 	 	 
	Signature:	 /s/ Hou Pu Jonathan Lin	 
	 	 	 
	Name:	 Hou Pu Jonathan Lin	 
	 	 	 
	Title:	 Chief Executive Officer	 

 

[Signature Page to Support Agreement]

 

     

     

    

 

IN WITNESS WHEREOF, each party has duly executed this Agreement, all
as of the date first written above.

 

	Integrated Whale Media Investment, Inc.	 
	 	 	 
	Signature:	 /s/ Yam Tak Cheung	 
	 	 	 
	Name:	 Yam Tak Cheung	 
	 	 	 
	Title:	 Director	 

 

[Signature Page to Support Agreement]

 

     

     

    

 

Schedule A

 

	Name
    of Shareholder	Number
    of Purchaser 

    Class B Shares	Number
    of Purchaser 

    Warrants	Address
    for Notice
	Sponsor(1)	4,500,000(1)	6,000,000(1)	Unit
                                            1009, ICBC 

                                            Tower

    Three Garden Road, 

    Central, Hong Kong

     

	Hou
    Pu Jonathan Lin(1)	4,500,000(1)	6,000,000(1)
	Ka
    Man Kevin Lee	162,500	/
	Frank
    Han	162,500	/
	Alexandre
    Mathieu Valdemar Casin	50,000	/
	Liu
    Xing Ling	25,000	/
	Wing
    Hong Sammy Hsieh	50,000	/
	Dickson
    Cheng	25,000	/
	Tung
    Wai Hui	25,000	/

 

(1) Mr. Jonathan Lin, who holds 100% of the voting securities
of Sponsor, may be entitled distributions of all Purchaser Class B Shares and Purchaser Warrants and has voting and investment discretion
with respect to all Purchaser Class B Shares and Purchaser Warrants held of record by Sponsor.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00332-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00332-of-00352.parquet"}]]